![](https://www.clevelandhiv.org/wp-content/uploads/2022/01/CMV-virus-schema-570x300.png)
Participant Summary Click here for a printable participant summary. Title: A5355 – Phase II, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-based anti-Cytomegalovirus (CMV) Vaccine (Triplex®), in Adults with Both Human Immunodeficiency Virus (HIV)-1 and CMV Who Are on Potent Combination ART […]